台灣生技醫藥產業的制度變遷

Institutional Change of Taiwan's Bio-Pharmaceutical Industry

10.30008/CD.201509_(23).0004

張喬婷(Chiao-Ting Chang)

制度 ； 生技醫藥產業 ； 創投 ； 群聚 ； 技術 ； institution ； bio-pharmaceutical industry ； venture capital ； cluster ； technology

城市與設計學報

23期（2015 / 09 / 01）

127 - 165

繁體中文

本文檢視台灣在發展生技醫藥產業時面臨之制度變遷的過程。首先，本文的主要發現為：在1990年代，台灣生技醫藥產業因跟隨先進國家的制度變遷而對產業產生重要的影響。其次，這些制度的再結構是為了適應全球性的調節(regulations)規範。本文將從行動者的權力關係來解釋，具有權力的行動者如何治理無權力的行動者來檢視灰色和重疊的領域，探討台灣生技醫藥產業的制度變遷。第三，為了更清楚理解台灣生技醫藥產業發展的過程，本研究從區分權力關係的變遷，包含具有權力及無權力兩種；以及從調節、資金、基礎建設和技術的四項推動力所形成八項架構的類型，來進一步概念化生技醫藥產業是一項政治驅動系統的動態變遷，並且分析這八項權力關係是透過許多行動者建立而形成。此外，本文也將從技術和領域的觀點來探討本土的大型製藥廠為了維持資金、基礎建設和技術的運作，前往中國大陸投資的行動。

The main task of this article is to investigate the role of institutional change in the development of Taiwan's bio-pharmaceutical industry. The major findings of this paper are first, in the 1990s the local's bio-pharmaceutical institution followed as the advanced national one played a leading role, and the advanced nations' institutional changes eventually became the most important global participant. Secondly, those institutions were restructured to adapt to the regulations globally. This article attempts to explain the gray and overlapping zone to investigate the role of institutional change in the development of Taiwan's bio-pharmaceutical industry. The explanation occurs as a result of changes in the power relationships among agents, or in the consequences desired by agents who are powerful enough to govern in bargaining with powerless ones. Thirdly, to be able to take due account of this, this research suggests to distinguish between power relationship of change, which may include either powerfulness or powerlessness, and impulses of change, which may include fund, infrastructure, and technology. It is to the exploration of eight types of changes that conceptualize properly current development in the political economy of Taiwan bio-pharmaceutical industry which is an outstanding example of the dynamism of the policy-driven system. These types of power relationship are built by heaps of agents. Moreover, in order to maintain the linkage to the market and technology, some agents began to invest in mainland China especially some local big Pharmas. In this article, technology and territorization are both used to explain the motivations of those firms to boarder-crossing.

1. Department of Economic Development (2006) “Taiwan's first center designed for biotechnology development” in Department of Economic Development, Taipei City, website, http://www.dortp.gov.tw/en/bio/bio_03.html
2. Chinatimes (2005) “Medicinal Herbs Biotech Park; More than ten firms have decided to station here” in Chinatimes, Apr. 9th, 2005
3. Executive Yuan Development Fund (EYDF) (2005)“ The Development Fund” April 25th , 2005. website, http://www.df.gov.tw/docs/
4. Huang, Rei-lian (2005) “Biotechnology and Technology in Taiwan”, Development ceneter of biotechnology, Sep. 06, 2005, http://www.biol.ntnu.edu.tw/biotechclass/
5. 中央社 (2006) 〈嘉義縣香草藥草生物科技園區動土〉，中央社，2006 年6 月30 日。
6. 行政院開發基金 (2005a)〈開發基金通過生技及生技創投投資4 案〉，《行政院開發基金新聞及公告》，2005 年3 月31 日。http://www.df.gov.tw/
7. 經濟部生醫小組 (2007b) 〈南港軟體園區生物技術館〉，《資料下載》，經濟部生醫小組網站。http://www.biopharm.org.tw/
8. 國家食品藥品監督管理局 (2007) 〈國家食品藥品監督管理局概況〉，《機構介紹》，國家食品藥品監督管理局網站。http://www.sfda.gov.cn/
9. SDA(State Drug Administration) (1999) “New Drug Application Principles”, in the State Council of PRC Bulletin , No.17 (No. 944 overall), May 31, 1999
10. NSTP (2005) Introduction, National Science and Technology Program(NSTP) for Biotechnology and Pharmaceuticals website, http://www.mc.ntu.edu.tw/~npbp/
11. North, Douglass C. (1994) ”Institutional Change: A Framework Of Analysis” in Economic History, 9412001, Economics Working Paper Archive EconWPA
12. 何俊輝 (2005)〈民間企業如何運用行政院開發基金共同發展文化創意產業〉，《行政院開發基金》，2005 年8 月25 日。http://www.df.gov.tw/docs/
13. HSP (2004) “Statistics-Development” in Hsinchu Science Park (HSP) website, http://eweb.sipa.gov.tw/en/dispatch.jsp?disp_to=11:39:24
14. Taiwan Economic News (2003) “Canadian fund representatives to visit Taiwan” in The Taiwan Economic News, Mar. 18, 2003
15. TVCA(Taiwan Venture Capital Association) (2003) “Venture capital: Status of Venture Capital Enterprise” in Executive Yuan Development Fund(EYDF) website, http://www.df.gov.tw/english/index4.html
16. 行政院科技顧問組 (2001) 《行政院第22 次科技顧問會議》，行政院科技顧問組。
17. Biopharm (2005) The Biotechnology and Pharmaceutical Industries Program Office (Biopharm), Ministry of Economic Affair (MOEA),website, http://www.biopharm.org.tw/
18. Ho, James C. (2005) “How to Use Resources of Development Fund to Develop Cultural & Creative Industries”, Executive Yuan Development Fund (EYDF), August 25th, 2005. website, http://www.df.gov.tw/docs/
19. MOEASMEA (2000) Statistics, in Small and Medium Enterprise Administration, Ministry of Economic, http://www.moeasmea.gov.tw/
20. Technology Review (2002) Technology Review Corporate R&D. http://www.technologyreview.com
21. 經濟部生醫小組 (2007a) 《經濟部、衛生署與生物醫藥業者溝通平台會議》，經濟部生醫小組網站。http://www.biopharm.org.tw/
22. MOEAIDB (2002) 'Two Trillion and Twin Star' Program, Industrial Development Bureau (IDB), in Ministry of Economic Affairs (MOEA) website, http://www.moeaidb.gov.tw/portal/web/ind1.jsp
23. 行政院開發基金 (2005b)〈行政院開發基金參與生物科技術民間投資情形彙整表〉，《行政院開發基金業務問答》，2005 年9 月22 日。http://www.df.gov.tw/
24. Bonacich, Edna(ed.)Cheng, Lucie(ed.)Chinchilla, Norma(ed.)Hamilton, Nora(ed.),Ong, Paul(ed.)(1994).Global Production: The Apparel Industry in the Pacific Rim.Philadelphia:Temple University Press.
25. Breschi, Stefano(ed.),Malerba, Franco(ed.)(2005).Clusters, Networks and Innovation.Oxford University Press.
26. Coenen, Lars,Moodysson, Jerker,Asheim, Bjørn(2004).Nodes, Networks and Proximities: On the Knowledge Dynamics of the Medicon Valley Biotech Cluster.European Planning Studies,12,1003-1018.
27. Cooke, Philip(2003).Biotechnology Clusters, 'Big Pharma' and the Knowledge-driven Economy.International Journal of Technology Management,25(1/2),65-80.
28. Cooke, Philip(2001).Biotechnology Clusters in the UK: Lessons from Localisation in the Commercialisation of Science.Small Business Economics,17,43-59.
29. Dicken, Peter(2001).Chains and networks, territories and scales: towards a relational framework for analysing the global economy.Global Networks,1(2),89-112.
30. DoIT(2004).Industrial Technology White Paper Book.Taipei:Department of Industrial Technology (DoIT), Ministry of Economy Affairs(MOEA)..
31. Dosi, Giovanni(1988).Technical change and economic theory.
32. Etzkowitz, Henry(Ed.),Leydesdorff, Loet(Ed.)(1997).Universities and the Global Knowledge Economy: A Triple Helix of University-Industry-Government Relations.London:Cassell.
33. Gereffi, Gary(ed.),eneniewicz, Miguel Korz(ed.)(1994).Commodity Chains and Global Capitalism.Praeger Publishers.
34. GIO(2005).Taiwan Yearbook: The Economy - Emerging Industries.
35. Hsu, Jinn-Yuh(2004).Towards a Late-industrial District: the Construction of Learning Networks in Hsinchu-Taipei Corridor, Taiwan.Alternative geographies of Asia in the new millennium: the East Asian Regional Conference on Alternative Geography (EARCAG) intervention
36. ITIS(2002).Biotechnology Industry Annual Report.Taipei:Development Center for Biotechnology, Industrial Technology Intelligence Services (ITIS) program, Ministry of Economy Affairs (MOEA).
37. Jessop, Bob(2000).The crisis of the national spatio-temporal fix and the tendential ecological dominance of globalizing captialism.International Journal of Urban and Regional Research,24(2),323-60.
38. Kenny, Martin(1986).Biotechnology: The university-lndustrial Complex.Yale University Press.
39. Kneller, Robert(2003).Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation.Research Policy,32,1805-1827.
40. Leydesdorff, Loet,Cooke, Philip,Olazaran, Mikel(2002).Technology Transfer in European Regions: Introduction to the Special Issue.Journal of Technology Transfer,27(1),5-13.
41. MOEAIDB(2004).Introduction to investment in the Biotechnology and Pharmaceutical Industries in Taiwan, Republic of China.Taipei:Industrial Development Bureau (IDB), Ministry of Economic Affair (MOEA).
42. North, Douglass C.(1990).Institutions, Institutional Change and Economic Performance.Cambridge:Cambridge University Press.
43. NSC(2004).Yearbook of Science and Technology Republic of China.Taipei:National Science Council(NSC), ROC(Taiwan).
44. Owen-Smith, Jason(2003).From Separate Systems to a Hybrid Order: Accumulative Advantage Across Public and Private Science at Research One Universities.Research Policy,32(6),1081-1104.
45. Owen-Smith, Jason,Powell, Walter W.(2004).Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community.Organization Science,15(1),5-21.
46. Powell, Walter W.(ed.),DiMaggio, Paul J.(ed.)(1991).The New Institutionalism in Organizational Analysis.University of Chicago Press.
47. Saxenian, AnnaLee(1994).Regional Advantage: Culture and Competition in Silicon Valley and Route 128.MA:Harvard University Press.
48. Saxenian, AnnaLee,Hsu, Jinn-Yuh(2001).The Silicon Valley-Hsinchu Connection: Technical Communities and Industrial Upgrading.Industrial and Corporate Change,10(4),893-920.
49. SMEA(2005).White Paper on Small and Medium Enterprises in Taiwan.Taipei:Small and Medium Enterprises Administration (SMEA)(MOEA),Taiwan.
50. Taiwan Venture Capital Association=TVCA(2005).TVCA Yearbook.TVCA.
51. Wilmut, Ian(1997).Viable offspring derived from fetal and adult mammalian cells.Nature,385,810-913.
52. Wong, Joseph(2011).Betting on Biotech:Innovation and the Limits of Asia's Developmental State.NY:Cornell Univ. Press.
53. Wong, Joseph(2004).South Korean biotechnology-a rising industrial and scientific powerhouse.Nature Biotechnology,22,DC42-C47.
54. 中華民國創業投資商業同業公會(2005)。2005 年台灣創業投資年鑑。中華民國創業投資商業同業公會。
55. 何美玥(2003)。創造臺灣新一波競爭力。臺灣經濟論衡，1(9)，1-35。
56. 宋勇徵(2005)。中加生物科技開發基金介紹。台肥季刊，47(3)，34。
57. 秦慶瑤、徐雅芬(2005)。生物技術產業年鑑2005。生物技術開發中心。
58. 國家科學委員會(2005)。行政院國家科學委員會九十四年年報。行政院國家科學委員會。
59. 郭坤峰、郭秋怡、梁淑嫻(2005)。農業生物科技園區規劃與建設。農政與農情，152
60. 陳琮淵、王振寰(2009)。台灣的生技製藥產業：發展、創新與限制。臺灣社會學刊，43，159 -20。
61. 游振偉(2006)。工業區土地出租政策檢討與建議。2006 年海峽兩岸暨兩岸四地土地學術研討會
62. 楊迺仁(2006)。客製化手機、費率結構、內容皆有待突破 行動應用產業話未來。電工資訊，190，38-40。
63. 經濟部工業局(2008)。生技產業白皮書。經濟部工業局。
64. 經濟部工業局(2010)。生技產業白皮書。經濟部工業局。
65. 經濟部工業局(2004)。生技產業白皮書。經濟部工業局。
66. 經濟部工業局(2006)。生技產業白皮書。經濟部工業局。
67. 經濟部生醫小組(2009)。生技新藥產業發展條例廣宣手冊。經濟部工業局。
68. 經濟部生醫小組(2009)。生技產業聯盟服務平台。經濟部生醫小組。
69. 經濟部技術處(2004)。2004 產業技術白皮書。經濟部技術處。